Elkington And Fife patent opposition analysis

The comprehensive analysis of Elkington And Fife opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Elkington And Fife

Patent NumberTitleApplicantOpposition DateOpposition Company
Methods Of Treating Heart Failure With Reduced Ejection Fraction With DapagliflozinASTRAZENECAJul 1, 2026GENERICS UK
Biphenyl Sulfonamide Compounds For The Treatment Of Type Iv Collagen DiseasesTRAVERE THERAPEUTICSJun 30, 2026TEVA PHARMACEUTICALS
Formulations Of Ag10EIDOS THERAPEUTICSJun 23, 2026TEVA PHARMACEUTICALS
Pharmaceutical Compositions Comprising CabotegravirVIIV HEALTHCAREJun 19, 2026ELKINGTON AND FIFE
Method For Moisturizing A Pouched Product For Oral UseSWEDISH MATCH NORTH EUROPEJun 10, 2026IMPERIAL TOBACCO
Methods Of Treating Hfpef Employing Dapagliflozin And Compositions Comprising The SameASTRAZENECAMay 20, 2026GENERICS UK
Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYOMay 19, 2026SOCIT DES PRODUITS NESTL
Oral Care Compositions And MethodsCOLGATE PALMOLIVEMay 6, 2026THE PROCTER & GAMBLE
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 28, 2026SANDOZ
Lactation Stage Specific Infant NutritionNUTRICIAApr 28, 2026SOCIT DES PRODUITS NESTL